Linked : Actualité Linked en direct - P7 | Bourse Reflex
Accueil > Tags > Linked

  • Toutes les actualités en rapport avec « Linked »

16/09 19:10 Linked - First phase successfully completed in the Group's transformation to a sustainable and profitable business model

16/09 19:00 Linked - 2015 Interim Financial Statements

16/09 18:30 Linked - Finalization of the acquisition of portuguese closures company PIEDADE SA

09/09 17:50 Linked - H1 2015 results : Current operating margin: +7.8% - Group net income: +63.8% - Interim dividend: EUR 0.13

08/09 18:30 Linked - Successfully restructured and presenting half-year results close to break-even for the first time, Theolia changes its name and becomes FUTUREN

08/09 18:00 Linked - Store Electronic Systems: 1st half-year results 2015

08/09 07:30 Linked - US patent granted for use of Genticel's antigen delivery vectors in combination therapy to treat cancer

02/09 18:00 Linked - INNOVEOX subsidiary SYNEOX announces the filing of a new revolutionary patent for the cold inertization of asbestos

01/09 18:00 Linked - GENTICEL to meet investors

28/07 18:00 Linked - Business Update - Second Quarter 2015

22/07 17:45 Linked - H1 2015 revenues - Revenue: EUR 134.6m Growth: 12.5%

21/07 23:00 Linked - Auplata announces first semester 2015 raw gold production: 143 kg - Favourable decision of Environmental Authority for Dieu Merci cyanide processing plant project

17/07 17:45 Linked - ACQUISITION OF PORTUGUESE CLOSURES COMPANY PIEDADE GROUP - FOR AN EVEN STRONGER MARKET POSITION IN CORK BOTTLE CLOSURES

07/07 18:00 Linked - Independent Data Safety Monitoring Board Recommends Continuation per Protocol of Genticel's Phase 2 Clinical Trial of GTL001 (ProCervix), Company's First-in-class HPV Therapeutic Vaccine Candidate

06/07 18:00 Linked - Six-months liquidity contract statement as of 30 june 2015

03/07 18:00 Linked - Summary of Genticel's liquidity contract with Oddo Corporate Finance

02/07 18:15 Linked - Genticel CFO, Martin Koch, Appointed CEO to Replace Benedikt Timmerman during Temporary Medical Leave of Absence

16/06 07:00 Linked - Genticel Receives FDA Clearance of IND Application for U.S. Phase 1 Clinical Trial of GTL001 (ProCervix), Company's First-in-class HPV Therapeutic Vaccine Candidate

08/06 18:00 Linked - 2014-2015 ANNUAL RESULTS : Strong increase in profitability Group net profit: +55%

01/06 07:00 Linked - Genticel Announces Positive Preclinical Proof of Concept Results of GTL002, its New Multivalent HPV Therapeutic Vaccine Candidate Based on Company's Versatile Vaxiclase Platform